Shares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than ...
The Motley Fool reports that biotech stocks surged in 2025, driven by FDA approvals and a doubling of longevity investment to ...
Zacks Investment Research on MSN
Puma Biotechnology stock declines more than 9% in a month: Here's why
Shares of Puma Biotechnology PBYI have tanked 9.6% in the past month, reflecting the growing investor concern regarding the ...
This clinical-stage biotech develops precision therapies for genetically defined diseases, targeting rare cancers and ...
Add Yahoo as a preferred source to see more of our stories on Google. Lululemon launched its first product using plant-based nylon in April 2023 Biotechnology is the exploitation of biological ...
AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...
The trial clearance for Shanghai-based Unixell is another step forward for the rapidly advancing Chinese biotech ecosystem, ...
Should include detailed information, to the extent practicable, on the degree of subsidization and market overcapacity by Chinese biotechnology firms and its impact on U.S. industry, including genomic ...
This week on "The Readout LOUD," a conversation with biotech "godfather" Stelios Papadapolous live from #STATBreakthrough.
Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, ...
Like the digital revolution, the biotech revolution stands to transform America’s economy as we know it, writes Eric Schmidt.
Anbio Biotechnology (NASDAQ: NNNN) ('Anbio' or the 'Company'), a global diagnostic company in in-vitro diagnostic (IVD) technologies, announced today that its CEO will participate in the upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results